Avadel Prepares to Seek FDA Approval of Lumryz in Pediatrics

Avadel provided a Q2 corporate update detailing the progress following Lumryz's approval by the FDA during the period.

Related Keywords

United States , American , Greg Divis , National Preferred Formulary , Drug Administration , Academy Of Sleep Medicine Foundation , Avadel Pharmaceuticals , Young Investigators Research Forum , American Academy Of Sleep Medicine , Research Society , Orphan Drug , New Drug Application , Express Scripts , American Academy , Sleep Medicine , Sleep Research , Sleep Medicine Foundation , Investigators Research ,